Finance

Beta
Lists
VRNS:NASDAQ
Varonis Systems Inc
$38.56
+3.41%
(+1.27) 1D
$38.80
+0.62% (+0.24)
Pre-market
Closed: Jun 25, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRNS...
Open
$37.06
High
$39.77
Low
$36.46
Mkt. cap
4.43B
Avg. vol.
2.03M
Volume
2.46K
52-wk high
$63.90
52-wk low
$19.70
EPS
-$1.13
Beta
0.89
Shares outstanding
114.81M
No. of employees
3K
Open
$37.06
High
$39.77
Low
$36.46
Mkt. cap
4.43B
Avg. vol.
2.03M
Volume
2.46K
52-wk high
$63.90
52-wk low
$19.70
EPS
-$1.13
Beta
0.89
Shares outstanding
114.81M
No. of employees
3K
News stories
From sources across the web
Profile
Varonis Systems, Inc. is a software company based in Miami, Florida with R&D offices in Herzliya, Israel. The company’s Data Security Platform analyzes data, identities, and activity to find and remediate data exposure in cloud and multi-cloud environments, and in software-as-a-service and infrastructure-as-a-service applications that include AWS, Azure, Google Cloud, Salesforce, ServiceNow, and databases. Varonis Atlas, launched in 2026, visualizes and controls AI tools, agents and copilots built and deployed by organizations, and integrates with the company's foundational platform to provide contextual information on AI use and misuse. Wikipedia
About Varonis Systems Inc
CEOYaki Faitelson
Employees2.66K
Founded2005
HeadquartersMiami, Florida, United States
SectorSoftware
Websitevaronis.com
Analyst ratings
Based on 21 analysts giving stock ratings to VRNS in the past 3 months
Strong buy
Buy
16
Hold
5
Sell
0
12-month forecast
Based on 21 Wall Street analysts offering 12 month price targets for VRNS in the last 3 months.
Highest
Current $38.56
$45.00 (+16.70%)
Average
$37.22 (-3.48%)
Lowest
$30.00 (-22.20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Ives
Wedbush
Buy
Maintained
$37.00
-4%
06/24/2026
Matthew Hedberg
RBC Capital
Buy
Maintained
$36.00
-6.6%
06/24/2026
Meta Marshall
Morgan Stanley
Hold
Maintained
$31.00
-19.6%
06/23/2026
Todd Weller CFA
Stephens
Buy
Upgraded
$45.00
+16.7%
06/24/2026
Mike Cikos
Needham
Buy
Reiterated
$40.00
+3.7%
06/23/2026
Richard Poland
Wells Fargo
Buy
Reiterated
$35.00
-9.2%
06/23/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
$35.00
-9.2%
06/22/2026
Jason Ader
William Blair
Hold
Maintained
-
-
06/03/2026
Shaul Eyal
TD Cowen
Buy
Reiterated
$40.00
+3.7%
05/28/2026
Eric Heath
KeyBanc
Hold
Initiated
-
-
05/26/2026
Catharine Trebnick
Rosenblatt Securities
Buy
Initiated
$40.00
+3.7%
05/11/2026
Fatima Boolani
Citi
Hold
Maintained
$30.00
-22.2%
04/30/2026
Rudy Kessinger
D.A. Davidson
Buy
Reiterated
$37.00
-4%
04/29/2026
Roger Boyd
UBS
Buy
Reiterated
$37.00
-4%
04/29/2026
Shyam Patil
Susquehanna
Buy
Maintained
$36.00
-6.6%
04/29/2026
Junaid Siddiqui
Truist Financial
Buy
Reiterated
$34.00
-11.8%
04/29/2026
Brian Essex
J.P. Morgan
Buy
Reiterated
$39.00
+1.1%
04/29/2026
Joseph Gallo
Jefferies
Buy
Maintained
$40.00
+3.7%
04/29/2026
Shrenik Kothari
Robert W. Baird
Hold
Maintained
-
-
04/28/2026
Jonathan Ruykhaver
Cantor Fitzgerald
Buy
Reiterated
$35.00
-9.2%
04/29/2026
Saket Kalia
Barclays
Buy
Maintained
$33.00
-14.4%
04/29/2026
Erik Suppiger
B. Riley Securities
Buy
Reiterated
$45.00
+16.7%
04/09/2026
Andrew Nowinski
Wells Fargo
Buy
Initiated
$28.00
-27.4%
03/03/2026
Rob Owens
Piper Sandler
Buy
Reiterated
$47.00
+21.9%
02/04/2026
Last report
Apr 28, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.06 / -$0.05
+209.77%beat
Revenue / Est. (USD)
173.13M / 165.50M
+4.61%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
152.16M
161.58M
173.37M
173.13M
Cost of goods sold
31.25M
35.15M
36.56M
41.57M
Cost of revenue
31.25M
35.15M
36.56M
41.57M
Research and development expenses
56.25M
62.74M
64.62M
69.76M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
101.22M
99.62M
102.45M
105.20M
Operating expense
157.47M
162.36M
167.07M
174.96M
Total operating expenses
188.72M
197.51M
203.63M
216.53M
Operating income
-36.55M
-35.93M
-30.26M
-43.40M
Other non operating income
-4.56M
-2.30M
3.12M
-3.14M
EBT including unusual items
-31.58M
-28.13M
-24.79M
-40.04M
EBT excluding unusual items
-31.58M
-28.13M
-26.00M
-38.08M
Income tax expense
4.24M
1.81M
2.98M
-3.18M
Effective tax rate
-13.42%
-6.45%
-12.03%
7.95%
Other operating expenses
-
-
-
-
Net income
-35.82M
-29.94M
-27.78M
-36.85M
Net profit margin
-23.54%
-18.53%
-16.02%
-21.29%
Earnings per share
0.03
0.06
0.08
0.06
Interest and investment income
12.35M
12.34M
12.21M
10.12M
Interest expense
-2.83M
-2.23M
-3.93M
-1.66M
Net interest expenses
9.53M
10.10M
8.28M
8.46M
Depreciation and amortization charges
-
-
-
-
EBITDA
-33.98M
-32.96M
-25.92M
-39.05M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of VRNS
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer